Position in ORGO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$27,850
-$36,132 QoQ
Shares Held
11,461
-57.5% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#94
of 134 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ORGO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026TWO SIGMA INVESTMENTS, LP holds $775,744,366 across 48 Drug Manufacturers - Specialty & Generic names. ORGO ranks #47 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
2,076,260 | $349,932,860 | |
| 2 | BCRX |
Biocryst Pharmaceuticals Inc
|
6,775,349 | $67,753,490 | |
| 3 | SUPN |
Supernus Pharmaceuticals, Inc.
|
1,184,378 | $55,085,420 | |
| 4 | ALKS |
Alkermes plc.
|
1,038,311 | $54,407,496 | |
| 5 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
561,480 | $35,906,646 | |
| 6 | ZTS |
Zoetis Inc.
|
386,428 | $27,768,716 | |
| 7 | LQDA |
Liquidia Corp
|
266,829 | $21,274,276 | |
| 8 | IRWD |
Ironwood Pharmaceuticals Inc
|
4,556,089 | $19,181,134 |
All Filings in ORGO
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $27,850 | 11,461 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $63,982 | 26,997 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,381,298 | 266,660 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $213,506 | 50,594 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $551,280 | 150,623 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,404,060 | 325,014 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,223,699 | 382,406 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $868,473 | 303,662 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $748,734 | 267,405 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,334,374 | 469,850 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $2,278,346 | 557,053 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,699,872 | 534,551 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $3,020,549 | 909,804 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,181,989 | 1,024,408 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $2,092,653 | 777,938 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $3,274,807 | 1,010,743 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,841,770 | 787,248 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $5,262,265 | 690,586 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $7,884,759 | 853,329 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $11,155,316 | 783,379 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $10,369,151 | 623,896 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $7,781,197 | 427,069 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,351,514 | 179,484 | Shares | Sole | 2021-02-16 | |
| 2020-03-31 | $151,038 | 46,761 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||